NCT/Study#

NCT03258931 /

ARO-021

Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in ACTIVEly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia

Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in ACTIVEly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia

DISEASE GROUP:
Leukemia
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: